GB9908513D0 - Molecular cloning of a new DNA sequence for protease activated receptor 2 - Google Patents

Molecular cloning of a new DNA sequence for protease activated receptor 2

Info

Publication number
GB9908513D0
GB9908513D0 GBGB9908513.6A GB9908513A GB9908513D0 GB 9908513 D0 GB9908513 D0 GB 9908513D0 GB 9908513 A GB9908513 A GB 9908513A GB 9908513 D0 GB9908513 D0 GB 9908513D0
Authority
GB
United Kingdom
Prior art keywords
dna sequence
molecular cloning
activated receptor
new dna
protease activated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9908513.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Southampton
Rolls Royce PLC
Original Assignee
University of Southampton
Rolls Royce PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Southampton, Rolls Royce PLC filed Critical University of Southampton
Priority to GBGB9908513.6A priority Critical patent/GB9908513D0/en
Publication of GB9908513D0 publication Critical patent/GB9908513D0/en
Priority to EP00927405A priority patent/EP1165790A1/en
Priority to MXPA01010380A priority patent/MXPA01010380A/en
Priority to PCT/GB2000/001455 priority patent/WO2000063371A1/en
Priority to JP2000612450A priority patent/JP2002541843A/en
Priority to CA002370272A priority patent/CA2370272A1/en
Priority to AU45812/00A priority patent/AU4581200A/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
GBGB9908513.6A 1999-04-15 1999-04-15 Molecular cloning of a new DNA sequence for protease activated receptor 2 Pending GB9908513D0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
GBGB9908513.6A GB9908513D0 (en) 1999-04-15 1999-04-15 Molecular cloning of a new DNA sequence for protease activated receptor 2
EP00927405A EP1165790A1 (en) 1999-04-15 2000-04-17 Protease activated receptor 2 variants
MXPA01010380A MXPA01010380A (en) 1999-04-15 2000-04-17 Protease activated receptor 2 variants.
PCT/GB2000/001455 WO2000063371A1 (en) 1999-04-15 2000-04-17 Protease activated receptor 2 variants
JP2000612450A JP2002541843A (en) 1999-04-15 2000-04-17 Mutants of protease activated receptor 2
CA002370272A CA2370272A1 (en) 1999-04-15 2000-04-17 Protease activated receptor 2 variants
AU45812/00A AU4581200A (en) 1999-04-15 2000-04-17 Protease activated receptor 2 variants

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9908513.6A GB9908513D0 (en) 1999-04-15 1999-04-15 Molecular cloning of a new DNA sequence for protease activated receptor 2

Publications (1)

Publication Number Publication Date
GB9908513D0 true GB9908513D0 (en) 1999-06-09

Family

ID=10851510

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9908513.6A Pending GB9908513D0 (en) 1999-04-15 1999-04-15 Molecular cloning of a new DNA sequence for protease activated receptor 2

Country Status (7)

Country Link
EP (1) EP1165790A1 (en)
JP (1) JP2002541843A (en)
AU (1) AU4581200A (en)
CA (1) CA2370272A1 (en)
GB (1) GB9908513D0 (en)
MX (1) MXPA01010380A (en)
WO (1) WO2000063371A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0213286D0 (en) 2002-06-10 2002-07-24 Univ Edinburgh Par-2-Activating peptide derivative and pharmaceutical composition using the same
FR2841559A1 (en) * 2002-06-28 2004-01-02 Pfizer MODIFIED RECEPTORS, PREPARATION AND USES
GB2450747A (en) * 2007-07-06 2009-01-07 Univ Sheffield Treatment of sensorineural hearing loss
US9745347B2 (en) 2010-12-30 2017-08-29 Hadasit Medical Research Services And Development Ltd. PAR1 and PAR2 c-tail peptides and peptide mimetics
US20220125898A1 (en) * 2019-05-03 2022-04-28 Janssen Biotech, Inc. Par2 modulation and methods thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874400A (en) * 1993-07-26 1999-02-23 Cor Therapeutics Recombinant C140 receptor, its agonists and antagonists, and nucleic acids encoding the receptor

Also Published As

Publication number Publication date
CA2370272A1 (en) 2000-10-26
WO2000063371A1 (en) 2000-10-26
AU4581200A (en) 2000-11-02
MXPA01010380A (en) 2003-07-21
JP2002541843A (en) 2002-12-10
EP1165790A1 (en) 2002-01-02

Similar Documents

Publication Publication Date Title
AU2903701A (en) Olfactory receptor sequences
EP0984692A4 (en) Novel angiogenesis inhibitors
EP1017682A4 (en) Novel angiogenesis inhibitors
HUP0004115A2 (en) Novel nucleotide sequences coding for the pck gene
HUP0201438A2 (en) Dna vaccine - pcv
AU140962S (en) A set of bottles
EP1100896A4 (en) Dna encoding snorf33 receptor
GB9908513D0 (en) Molecular cloning of a new DNA sequence for protease activated receptor 2
IL145677A0 (en) Pcr-based cloning method
GB2363479B (en) A linker using relocation sequences
HUP0200319A3 (en) Molecular profiling for heterosis selection
AU7622600A (en) Ascot collar bar
EP1053253A4 (en) Novel gaba b? receptor dna sequences
HK1047113A1 (en) A DNA MOLECULE ENCODING A VARIANT α2B-ADRENOCEPTOR PROTEIN, AND USES THEREOF
EP1094071A4 (en) Novel peptide y-2
AU5903000A (en) Novel anti-thrombin peptide
HK1049799A1 (en) Tertiary amino compounds having opioid receptor affinity
HK1049352A1 (en) Dna encoding a novel prost-ets polypeptide
GB9908920D0 (en) Peptide
GB9924604D0 (en) Genetic switch
GB0111437D0 (en) Molecular cloning of a P2Y-like seven transmembrane receptor (AXOR89)
ZA981891B (en) Peptides useful as somatostatin antagonists.
GB9910348D0 (en) Novel DNA sequences
GB0107384D0 (en) Molecular cloning of a 7TM receptor (AXOR64)
GB9918593D0 (en) Novel peptides